PD
At a glance
Registered since
2024
Senate LDA system
Clients
10
last 3 years
Filings
22
4 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Director
Office of Intergovernmental and External Affairs, U.S. Dept. of Health and Human Services
2009-2015
Disclosed on LD-2 filings
Career
F
Specific issues
Issues related to alternative treatments for PTSD and research in treating behavioral health challenges.
Issues pertaining to payment for healthcare services.
Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency; Issues related to S. 127 - Pharmacy Benefit Manager Transparency Act of 2023; Issues related to S. 1339 - Pharmacy Benefit Manager Reform Act; Issues related to H.R. 3561 - PATIENT Act of 2023; Issues related to S. 2973 - Modernizing and Ensuring PBM Accountability Act; Issues related to H.R. 5378 - the Lower Costs, More Transparency Act.
Issues related to Medicare reimbursement, workforce issues, and the implementation of the No Surprises Act (PL 116-260).
Transportation issues regarding medical transport; Issues related to S. 1939 - FAA Reauthorization Act of 2024.
Issues related to infectious disease diagnosis and value based care.
Clients
Filing history
LYKOS THERAPEUTICS
INDEPENDENT PHARMACY COOPERATIVE
CLARITEV (FKA MULTIPLAN CORPORATION)
VIR BIOTECHNOLOGY, INC.
GLOBAL MEDICAL RESPONSE
MOLINA HEALTHCARE, INC.
TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION
CYTOVALE, INC.
CLARITEV (FKA MULTIPLAN CORPORATION)
HEALTHY.IO (US), INC.
LYKOS THERAPEUTICS
CLARITEV (FKA MULTIPLAN CORPORATION)